These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 16755582)

  • 1. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease.
    Di Paola M; Luders E; Cherubini A; Sanchez-Castaneda C; Thompson PM; Toga AW; Caltagirone C; Orobello S; Elifani F; Squitieri F; Sabatini U
    Cereb Cortex; 2012 Dec; 22(12):2858-66. PubMed ID: 22223853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity.
    Wang HC; Hsu JL; Leemans A
    Arch Neurol; 2012 Oct; 69(10):1340-8. PubMed ID: 22825428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits.
    Bohanna I; Georgiou-Karistianis N; Sritharan A; Asadi H; Johnston L; Churchyard A; Egan G
    Brain Imaging Behav; 2011 Sep; 5(3):171-80. PubMed ID: 21437574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
    Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
    Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related alterations in white matter microstructure measured by diffusion tensor imaging.
    Salat DH; Tuch DS; Greve DN; van der Kouwe AJ; Hevelone ND; Zaleta AK; Rosen BR; Fischl B; Corkin S; Rosas HD; Dale AM
    Neurobiol Aging; 2005; 26(8):1215-27. PubMed ID: 15917106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of displaced white matter by brain tumors using combined DTI and fMRI.
    Schonberg T; Pianka P; Hendler T; Pasternak O; Assaf Y
    Neuroimage; 2006 May; 30(4):1100-11. PubMed ID: 16427322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.
    Klöppel S; Draganski B; Golding CV; Chu C; Nagy Z; Cook PA; Hicks SL; Kennard C; Alexander DC; Parker GJ; Tabrizi SJ; Frackowiak RS
    Brain; 2008 Jan; 131(Pt 1):196-204. PubMed ID: 18056161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter impairment in the basal ganglia-thalamocortical circuit of drug-naïve childhood absence epilepsy.
    Yang T; Guo Z; Luo C; Li Q; Yan B; Liu L; Gong Q; Yao D; Zhou D
    Epilepsy Res; 2012 May; 99(3):267-73. PubMed ID: 22227509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial changes in the white matter diffusion tensor imaging metrics in moderate traumatic brain injury and correlation with neuro-cognitive function.
    Kumar R; Husain M; Gupta RK; Hasan KM; Haris M; Agarwal AK; Pandey CM; Narayana PA
    J Neurotrauma; 2009 Apr; 26(4):481-95. PubMed ID: 19196176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
    Rosas HD; Lee SY; Bender AC; Zaleta AK; Vangel M; Yu P; Fischl B; Pappu V; Onorato C; Cha JH; Salat DH; Hersch SM
    Neuroimage; 2010 Feb; 49(4):2995-3004. PubMed ID: 19850138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
    Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
    J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment.
    Chua TC; Wen W; Chen X; Kochan N; Slavin MJ; Trollor JN; Brodaty H; Sachdev PS
    Am J Geriatr Psychiatry; 2009 Jul; 17(7):602-13. PubMed ID: 19546655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease.
    Rosas HD; Wilkens P; Salat DH; Mercaldo ND; Vangel M; Yendiki AY; Hersch SM
    Neuroimage Clin; 2018; 20():236-242. PubMed ID: 30090698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion changes in patients with systemic lupus erythematosus.
    Zhang L; Harrison M; Heier LA; Zimmerman RD; Ravdin L; Lockshin M; Uluğ AM
    Magn Reson Imaging; 2007 Apr; 25(3):399-405. PubMed ID: 17371731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.
    Di Paola M; Di Iulio F; Cherubini A; Blundo C; Casini AR; Sancesario G; Passafiume D; Caltagirone C; Spalletta G
    Neurology; 2010 Apr; 74(14):1136-42. PubMed ID: 20368633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.